Silverarc Capital Management, LLC Kura Oncology, Inc. Transaction History

Silverarc Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$11.78 - $16.98 $787,045 - $1.13 Million	-66,812 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.22 - $19.57 $124,619 - $199,574	10,198 Added 18.01%	66,812 $935,000
Q3 2021 Nov 15, 2021	SELL	$15.42 - $21.72 $400,287 - $563,829	-25,959 Reduced 31.44%	56,614 $1.06 Million
Q2 2021 Aug 16, 2021	BUY	$20.85 - $29.88 $53,647 - $76,881	2,573 Added 3.22%	82,573 $1.72 Million
Q1 2021 May 18, 2021	SELL	$24.75 - $39.14 $247,500 - $391,400	-10,000 Reduced 11.11%	80,000 $2.26 Million
Q4 2020 Feb 16, 2021	BUY	$29.0 - $41.62 $2.61 Million - $3.75 Million	90,000 New	90,000 $2.94 Million

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.